Bioalpha Holdings Berhad, an investment holding company, engages in the manufacture and sale of health supplement products in Malaysia, China, and internationally. The company operates through two segments, Trading and Manufacturing. The company also engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional food, and healthcare products; import, export, cultivation, manufacture, distribution, and trade of various agro products and medical herbs; and planting, growing, and trade of herbs, fruits, agricultural, and agro and organic products. In addition, the company is involved in the wholesale and retail trade of pharmaceutical and traditional medicines, healthcare, nutritional products, and food and beverages; procurement and sale of agricultural products; land development services; import and export of medicines and edible bacteria; sale of food through the internet; and management and consulting activities. Further, it operates pharmacy retail outlets under the Constant Pharmacy brand and concept shops, as well as acts as online trading agents and franchisors. The company was incorporated in 2005 and is headquartered in Bandar Baru Bangi, Malaysia.
Research context
Bioalpha Holdings Bhd appears in PyInvesting’s Kuala Lumpur Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- MYR
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Bioalpha Holdings Bhd is currently in a long term downtrend where the price is trading 22.2% below its 200 day moving average.
From a valuation standpoint, the stock is 17.5% cheaper than other stocks from the Other sector with a price to sales ratio of 5.3.
Bioalpha Holdings Bhd's total revenue sank by 60.2% to $7M since the same quarter in the previous year.
Its net income has dropped by 412.7% to $-10M since the same quarter in the previous year.
Finally, its free cash flow fell by 119.1% to $-3M since the same quarter in the previous year.
Based on the above factors, Bioalpha Holdings Bhd gets an overall score of 1/5.